Print

Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.

Achieved jury verdict for plaintiffs of $8,279,300, including $7.8 million in punitive damages, for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson's drug Mirapex.